Skip to content

Evaluation of an Open-Label Placebo Appetite suppressant - An eye-tracking study

Evaluation of an Open-Label Placebo Appetite suppressant - An eye-tracking study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00031301
Enrollment
52
Registered
2023-03-10
Start date
2023-03-17
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy participants

Interventions

Group 1: Open-label placebo to reduce preference for/appetite for sugar. A placebo capsule (vegan white capsule filled with cornstarch
capsule size 00) will be taken once directly at the beginning of the session. After capsule ingestion, participants view food images in 60 trials (a 6s), with nonspecific appetite assessed every 20 tr

Sponsors

Universität Graz
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Normal or corrected-to-normal vision at 1m distance

Exclusion criteria

Exclusion criteria: Medication that may affect eating beavior/appetite.

Design outcomes

Secondary

MeasureTime frame
Exploratory analysis of associations between efficacy expectations of participants and actual reductions in appetite for/attention to high-calorie (high-sugar) foods(illustrations). The German language version of the Eating Disorder Examination Questionnaire is used for the sample description.

Primary

MeasureTime frame
Immediately after ingestion of the placebo (omitted in the control condition), eye movements are recorded while looking at food images, and appetite is recorded every 20 trials (6-point Likert scale). Subsequently, the specific appetite for a subset of the presented foods is elicited. Finally, a (sweet) taste sample is rated (Intensität und Präferenz).

Countries

Austria

Contacts

Public ContactJonas Potthoff

Universität Graz

jonas.potthoff@uni-graz.at+43 (0)316 380 - 3883

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026